3EAX
Crystal structure PTP1B complex with small molecule compound LZP-6
3EAX の概要
| エントリーDOI | 10.2210/pdb3eax/pdb |
| 関連するPDBエントリー | 3EB1 |
| 分子名称 | Tyrosine-protein phosphatase non-receptor type 1, 4,4'-piperazine-1,4-diylbis{1-[3-(benzyloxy)phenyl]-4-oxobutane-1,3-dione} (3 entities in total) |
| 機能のキーワード | protein tyrosine phosphatase, ptp1b, inhibitor, acetylation, endoplasmic reticulum, hydrolase, membrane, oxidation, phosphoprotein, polymorphism, protein phosphatase |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Endoplasmic reticulum membrane; Peripheral membrane protein; Cytoplasmic side: P18031 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 38012.32 |
| 構造登録者 | Zhang, Z.-Y.,Liu, S.,Zhang, L.-F.,Yu, X.,Xue, T.,Gunawan, A.M.,Long, Y.-Q. (登録日: 2008-08-26, 公開日: 2009-07-07, 最終更新日: 2024-02-21) |
| 主引用文献 | Liu, S.,Zeng, L.F.,Wu, L.,Yu, X.,Xue, T.,Gunawan, A.M.,Long, Y.Q.,Zhang, Z.Y. Targeting inactive enzyme conformation: aryl diketoacid derivatives as a new class of PTP1B inhibitors. J.Am.Chem.Soc., 130:17075-17084, 2008 Cited by PubMed Abstract: There has been considerable interest in protein tyrosine phosphatase 1B (PTP1B) as a therapeutic target for diabetes, obesity, as well as cancer. Identifying inhibitory compounds with good bioavailability is a major challenge of drug discovery programs targeted toward PTPs. Most current PTP active site-directed pharmacophores are negatively charged pTyr mimetics which cannot readily enter the cell. This lack of cell permeability limits the utility of such compounds in signaling studies and further therapeutic development. We identify aryl diketoacids as novel pTyr surrogates and show that neutral amide-linked aryl diketoacid dimers also exhibit excellent PTP inhibitory activity. Kinetic studies establish that these aryl diketoacid derivatives act as noncompetitive inhibitors of PTP1B. Crystal structures of ligand-bound PTP1B reveal that both the aryl diketoacid and its dimeric derivative bind PTP1B at the active site, albeit with distinct modes of interaction, in the catalytically inactive, WPD loop open conformation. Furthermore, dimeric aryl diketoacids are cell permeable and enhance insulin signaling in hepatoma cells, suggesting that targeting the inactive conformation may provide a unique opportunity for creating active site-directed PTP1B inhibitors with improved pharmacological properties. PubMed: 19012396DOI: 10.1021/ja8068177 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.9 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






